Tania Jain

47PUBLICATIONS
264CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Oct 07, 2026
Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.

|Aug 31, 2026
Incidence, prevalence, and survival outcomes of patients with myeloproliferative neoplasms in the United States: a Surveillance, Epidemiology, and End Results (SEER) database analysis, years 2000-2021.

|May 18, 2026
Incidence, Prevalence, and Survival Outcomes of Patients with Myeloproliferative Neoplasms in the United States: a SEER database analysis, years 2000-2021.

|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur

|Jan 21, 2026
Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome.

Hannah R Davidson-Swinton, Sheila Iyer, Anna Kolchinski

|Dec 15, 2025
Risk and Outcomes of Second Malignancies in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasm: A SEER Database Analysis.

Rahul Mishra, Arindam Bagga, Noha Sharafeldin

Pageof 8

Frequent Collaborators

6 joint publications

Miguel-Angel Perales

5 joint publications

William Brian Dalton

4 joint publications

Jonathan Webster

4 joint publications

Taiga Nishihori